Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • “Discovering the Original Meaning of Varna: A Highlight of Badrinath’s Jayam” Business
  • Fashion Wizards Grand Events presents Grand Assam 2022 concludes in Guwahati Lifestyle
  • Progressive Universities Essential to Facilitate Global Engagement to Address Complex Challenges, says Canada’s York University VC, Prof. Dr. Rhonda L. Lenton Education
  • Chandni Soni Renowned Producer is back with Bumpy Ride of a Gujarati family Entertainment
  • Technology Is the Answer to all the challenges of Start Ups & Businesses across the globe Says Ajay Sharma, Founder of DBC Business
  • Country’s well-known company Pooja Movie Creations is bringing 5 big projects in 2023 in new financial Business
  • Elgin Hotel And Resorts Announces The Appointment Of Rea Oberoi As Its Vice President Business
  • An insightful new book from Shradha Agarwal about the makeup industry is released Lifestyle

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Aarthi Scans and Labs Launches ‘Vital MRI’: A New Chapter in Preventive Healthcare with Full Body MRI Scans Health
  • Vyas Hospital and Andro-Genta Clinics: Best Urology Hospital in Jaipur Health
  • Drugs Manufacturer from Hyderabad on overdrive A
  • Diagnoses, Tips and Care for Dengue amid Monsoon Surge Health
  • Innovative Egg ‘Rejuvenation’ Techniques Boost IVF Success for Women with Low Ovarian Reserve at Nisha IVF Centre Health
  • A Birthday of Purpose: Nirav Shah Inspires 350+ Blood Donations in Surat Health

Recent Posts

  • WhatsApp’s Username Dream Meets India’s Reality Check
  • Google’s Android Setback Is Bigger Than A Fine—It’s A Blueprint For Big Tech’s Future
  • When The Music Stops, Legends Don’t: Victor Willis Leaves Behind More Than Just Y.M.C.A.
  • Hollywood’s Biggest Bet Of 2026 Isn’t A New Story—It’s Your Memory
  • Actor Suraj’s Performance in ‘Tera Mera Nata’ Wins Audience Appreciation as Film Continues Successful Second-Week Run

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Kingston Technology Remains Top DRAM Module Supplier for 2022 Business
  • Unveiling Surat’s Premier Destination: GJHM Introduces Luxury Hotel, Convention Center, and Golf Course in Gujarat Business
  • Durian Furniture launched its 2nd Odisha showroom in Bhubaneshwar Business
  • JD Cables Limited Reports Strong H2 FY26 & FY26 Performance Business
  • ORRA Celebrates 25th Anniversary with Resounding Success at Jewellery Fest Event, Offers Extended Till May 12th, 2024 Business
  • RealtyCheck 6.0 by Realatte Brings Together Real Estate and Global Tech Leaders to Decode Real Estate’s 2026 Growth Code Business
  • Syed Ali Dujana Gurdezi Honoured with “I Am Peacekeeper – Champion Justice and Peace Award” at Billionaires for Peace Conclave 2026 Lifestyle
  • Hide Away Pocket Door System by Hafele Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme